Demystifying the Role of Tumor Mutational Burden for Immunotherapy Selection-Reply

JAMA Oncol. 2020 Nov 1;6(11):1809-1810. doi: 10.1001/jamaoncol.2020.3397.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers, Tumor
  • Humans
  • Immunotherapy*
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • Neoplasms* / therapy

Substances

  • Biomarkers, Tumor